Big Pharma under investigation
Author: Elio F. Gagliano, MD
Article Published: 21/01/2008
If anyone has ever wondered if FORCES's accusations regarding Big Pharma were the maniacal materialization of an enemy to fight, like Don Quixote's windmills, read the following news:
Neelie Kroes, European Commissioner for Competition Policy.
Commission launches sector inquiry into pharmaceuticals.
Introductory remarks at press conference.
Antitrust: Commission launches sector inquiry into pharmaceuticals with unannounced inspections.
The European Commission has launched a sector inquiry into competition in the pharmaceuticals sector (under Article 17 of Regulation 1/2003), and is conducting inspections at the premises of a number of innovative and generic pharmaceutical companies. The inquiry is a response to indications that competition in pharmaceutical markets in
It is estimated that, within the European Union, the pharmaceutical companies handle €400 billions, equivalent to about $586 billions. If it is nearly impossible to figure out what is the stake on game in the world market, it is easy, instead, to imagine how simple it must be to buy governments, no matter if democratic or openly dictatorial!
Neelie Kroes suspects that the pharmaceutical tycoons are not acting according to market regulations. The reasons for the suspicion are not officially stated, but we can figure them out on our own.
Among the companies investigated are: Glaxo, Johnson & Johnson, Novartis, and Sanofi-Aventis.
We'll be looking forward to seeing the final results of the investigation.
Link To Original Article »»
Link To Stored Article »»